An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity

Publisher： Karger

E-ISSN： 1423-0399|89|3|259-269

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.89, Iss.3, 2012-07, pp. : 259-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

By Wyndaele Jean-Jacques  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 485-494

Future Medicine

Access to resources Recommend Favorite

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment

By  

BJU INTERNATIONAL, Vol. 116, Iss. 6, 2015-12 ,pp. : 853-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

A Portable Device for Experimental Treatment of Neurogenic Detrusor Overactivity

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 158-165

John Wiley & Sons Inc

Access to resources Recommend Favorite